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A brain-computer interface (BCI) is a new communica-
tion channel between the human brain and a computer
without using any muscle activities. Applications of BCI
systems comprise communication, restoration of move-
ments or environmental control [1].
W i t h i nt h i ss t u d yw ep r o p o s eac o m b i n e dP 3 0 0[ 2 ]
and steady state visually evoked potential (SSVEP, [3])
based BCI system for controlling a smart home in a vir-
tual environment implementation with a high accuracy
and a high degree of freedom. The system shows 20 to
45 selectable commands on a computer screen. When-
ever a target command is flashing up, a P300 response
can be detected from the ongoing brain activity and a
control command is initiated. However, some command
groups like “move right, move left, move forward, and
move backward or stop” d on o tn e e da ne x t e n d e du s e r
interface. For such commands a SSVEP based BCI
approach was implemented consisting of light sources
flickering at user selectable different frequencies. The
subject simply watches one of the flashlights. Specific
commands are connected with the different flickering
lights. The user selected command can be detected as
the same flickering frequency can be found in the brain
activity. A further big advantage of the implemented
approach is that the so-called zero class (no command
is selected) is reliably detected. Hence even a direct con-
trol of a device can be realized. If the subject does not
want to control the device then he/she simply ignores
the flashing lights. A total of 12 subjects participated in
the P300 experiment and the mean accuracy was 79.3 %,
69.6 % and 53.6 % for 8, 4 and only 2 flashes per item.
The best result was achieved for subject 6 with 100 %
accuracy for 8 and 4 flashes. The worst results had sub-
ject 3 with only 30 % accuracy for 2 flashes. A total of 3
subjects participated in the SSVEP experiment displaying
a mean error rate of 3-5%.
Conclusion
The combination of a P300 and SSVEP based BCI
allows realizing both i) a synchronous goal orientated
control system using the P300 interface satisfying the
intention of the user more naturally, e.g. sending the
command grasp a glass of water; here one can select a
command from a large command base and ii) a reliable
asynchronous more direct control of devices based on a
SSVEP interface; here just a few commands can be
selected with very good performance including zero-
class detection.
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